NeoGenomics, Inc. (NEO) vs Tectonic Therapeutic, Inc. (TECX)
A side-by-side comparison of NeoGenomics, Inc. and Tectonic Therapeutic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$16.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TECX
Tectonic Therapeutic, Inc.
$22.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NEO vs TECX
growth of $100 · dividends reinvested · last 8yNEO +47.3% (+5.0%/yr)TECX -93.8% (-29.4%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
NEO TECX
NEO vs TECX: by the numbers
- •NEO is the larger company ($424M vs $423M market cap).
- •Both run net losses; TECX's is the smaller (0.00% vs -6.77% net margin).
Metrics side by side
Valuation
| Metric | NEO | TECX |
|---|---|---|
| Forward P/E | 90.32 | N/A |
| P/S ratio | 0.55 | N/A |
| P/B ratio | 0.54 | 1.89 |
Profitability
| Metric | NEO | TECX |
|---|---|---|
| Gross margin | 42.92% | 0.00% |
| Operating margin | -8.63% | 0.00% |
| Net margin | -6.77% | 0.00% |
| ROE | -6.60% | -38.32% |
| ROIC | -5.29% | -41.88% |
Growth (annualized)
| Metric | NEO | TECX |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | N/A |
| Total return CAGR (5Y) | -15.14% | -18.45% |
Frequently asked
- How have NEO and TECX total returns compared?
- Over the past 5 years, NEO delivered -15.14% and TECX delivered -18.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.